RIGEL PHARMACEUTICALS INC — Director's Dealing 2020

May 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2020-05-15

Reporting Person: Wasman Jane (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-15	Stock Option (Right to Buy)	$1.765	A	55000	Acquired	2030-05-15	Common Stock (55000)	Direct

Footnotes

F1: The shares vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors.